Publication | Open Access
Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells
68
Citations
24
References
2018
Year
BBR suppresses tumorigenicity of TNBC cells through inhibition of TGF-β1 expression. Therefore, we demonstrate that BBR could be a promising drug for treatment of TNBC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1